Search Within

Jedd D Wolchok

  1. "2012"
Formats
  1. Meeting Abstract (27)
  2. Journal Article (20)
  3. Book Section (1)
Groups
  1. Department of Medicine (48)
  2. GSK Faculty (48)
  3. Melanoma and Immunotherapeutics Service (48)
  4. Solid Tumor Oncology Division (48)
  5. Melanoma Disease Management Team (14)
  6. Hematologic Malignancies, Division of (11)

More Groups

People
  1. Margaret Callahan (12)
  2. Michael Postow (12)
  3. Jianda Yuan (9)
  4. Paul Chapman (7)
  5. Taha Merghoub (7)
  6. Richard Carvajal (6)

More People

Years
  1. 2012 (48)
Publications
  1. Journal of Clinical Oncology (11)
  2. Annals of Oncology (6)
  3. Asia-Pacific Journal of Clinical Oncology (3)
  4. Cancer Research (3)
  5. New England Journal of Medicine (3)
  6. International Journal of Radiation Oncology, Biology, Physics (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. Oxford University Press (6)
  3. Nature Publishing Group (5)
  4. Wiley Blackwell (5)
  5. American Association for Cancer Research (4)
  6. Elsevier Inc. (4)

More Publishers

Results (48)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ipilimumab (IPI) expanded access program (EAP) for patients (pts) with stage III/IV melanoma: Safety data by subgroups
    Meeting Abstract

    Lawrence, D.; McDermott, D. F.; Hamid, O.; Weber, J. S.; Wolchok, J. D.; Richards, J.; Amin, A.; Bennett, K.; Balogh, A.; Hodi, F. S.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Effects of chemotherapy on ipilimumab-mediated increases in absolute lymphocyte count and activation of T cells
    Meeting Abstract

    Chasalow, S. D.; Wolchok, J. D.; Reck, M.; Maier, S.; Shahabi, V.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • A phase 2 randomized study of ramucirumab (IMC 1121B; RAM) with or without dacarbazine (DTIC) in patients (pts) with metastatic melanoma (MM) (CP12-0604/NCT00533702)
    Meeting Abstract

    Carvajal, R.; Thompson, J.; Gordon, M.; Lewis, K.; Pavlick, A.; Wolchok, J.; Rojas, P.; Schwartz, J.; Bedikian, A.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas
    Journal Article

    Lito, P.; Pratilas, C. A.; Joseph, E. W.; Tadi, M.; Halilovic, E.; Zubrowski, M.; Huang, A.; Wong, W. L.; Callahan, M. K.; Merghoub, T.; more...
    Cancer Cell (2012)

    Fulltext@MSK | Save
  • How recent advances in immunotherapy are changing the standard of care for patients with metastatic melanoma
    Journal Article

    Wolchok, J.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Modulation of GITR for cancer immunotherapy
    Journal Article

    Schaer, D. A.; Murphy, J. T.; Wolchok, J. D.
    Current Opinion in Immunology (2012)

    Fulltext@MSK | Save
  • Monoclonal antibodies in cancer therapy
    Journal Article

    Scott, A. M.; Allison, J. P.; Wolchok, J. D.
    Cancer Immunity (2012)

    Fulltext@MSK | Save
  • Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
    Journal Article

    Peinado, H.; Alečković, M.; Lavotshkin, S.; Matei, I.; Costa-Silva, B.; Moreno-Bueno, G.; Hergueta-Redondo, M.; Williams, C.; García-Santos, G.; Ghajar, C. M.; more...
    Nature Medicine (2012)

    Fulltext@MSK | Save
  • Targeting intracellular antigens using chimeric antigen receptors
    Meeting Abstract

    Maus, M. V.; Merghoub, T.; Jakka, G.; Plotkin, J.; Stewart-Jones, G.; Riviere, I.; Wolchok, J.; Renner, C.; Sadelain, M.
    Molecular Therapy (2012)

    Fulltext@MSK | Save
  • Abscopal effect in a patient with melanoma - The authors reply
    Journal Article

    Postow, M. A.; Callahan, M. K.; Wolchok, J. D.
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save